AzureBio, Madrid, Spain   Report issue

For profit Phase 2
Founded: Tres Cantos Spain (2007)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2014
NCT02639572
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

calcium phosphate (1 trial)

hydroxyapatite silica (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 2)

Periodontitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2